Drug Shortage Report for LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP
Report ID | 139438 |
Drug Identification Number | 02436221 |
Brand name | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP |
Common or Proper name | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE |
Company Name | HIKMA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | EPINEPHRINE LIDOCAINE HYDROCHLORIDE |
Strength(s) | 0.01MG 20MG |
Dosage form(s) | SOLUTION |
Route of administration | BLOCK/INFILTRATION BLOCK/INFILTRATION |
Packaging size | 50 mL |
ATC code | N01BB |
ATC description | ANESTHETICS, LOCAL |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-05-14 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2021-05-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-05-15 | English | Compare |
v3 | 2021-05-14 | French | Compare |
v2 | 2021-05-14 | English | Compare |
v1 | 2021-05-14 | English | Compare |
Showing 1 to 4 of 4